Unknown

Dataset Information

Personalized Disease Monitoring in Pediatric Onset Multiple Sclerosis Using the Saliva Free Light Chain Test.


ABSTRACT:

Background

Development of new safe methods of monitoring disease activity in the pediatric onset multiple sclerosis (POMS) is a challenging task, especially when trying to refrain from frequent MRI usage. In our recent study, the saliva immunoglobulin free light chains (FLC) were suggested as biomarkers to discriminate between remission and active MS in adults.

Objectives

To assess utility of saliva FLC measurements for monitoring disease activity in POMS.

Methods

We used semiquantitative Western blot analysis to detect immunoreactive FLC monomers and dimers and to calculate the intensity of their bands. Statistical tests included Firth logistic regression analysis suitable for small sample sizes, and Spearman's non-parametric correlation.

Results

In

SUBMITTER: Ganelin-Cohen E 

PROVIDER: S-EPMC9016751 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature